Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety and Pharmacokinetics of Ascending Dosages of Emodepside and in Comparison to Ivermectin Against Strongyloidiasis Stercoralis in Adults: Randomized Stage II Seamless Adaptive Controlled Trials

NCT06373835 is registered in ClinicalTrials.gov with Swiss Tropical & Public Health Institute as lead sponsor.

NCT NCT06373835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06373835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety and Pharmacokinetics of Ascending Dosages of Emodepside and in Comparison to Ivermectin Against Strongyloidiasis Stercoralis in Adults: Randomized Stage II Seamless Adaptive Controlled Trials
Lead sponsor
Swiss Tropical & Public Health Institute
Phase
Phase 2
Overall status
Completed
Start date
May 20, 2024
Completion date
September 21, 2024
Enrollment
202 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

strongyloides stercoralis infection, strongyloidiasis